Tackling NAFLD : Silent Epidemic

CASE DISCUSSION

Tackling NAFLD : Silent Epidemic

India flagPresented from India by Dr. Suhas Gopal Erande

0

Likes

2842

Views

114

Shares

114

Bookmarks

Case Description

Non-Alcoholic Fatty Liver Disease (NAFLD) is a silent epidemic characterized by the accumulation of fat in the liver due to factors other than alcohol consumption. Lifestyle changes play a pivotal role in tackling NAFLD, with emphasis on adopting a balanced diet and engaging in regular physical...

Case Summary

  • NAFLD (Non-Alcoholic Fatty Liver Disease) is increasingly prevalent globally, affecting over 25% of adults and even more in diabetic populations, with rates in India ranging from 35% to potentially 100%. This has led to a shift in nomenclature from NAFLD to MASLD (Metabolic Dysfunction-Associated Steatotic Liver Disease) to deemphasize alcohol as a causative factor and recognize the association with metabolic dysfunction. Other related terms include VASLD, LLD, NASID, and IRASLD.

Speaker Profile

Dr. Suhas Gopal Erande

Dr. Suhas Gopal Erande

Academic Member of RSSDI Senior Consultant Physician, Akshay Hospitals, Pune
Dr. Suhas Erande, the founder of Akshay Hospital & Diabetic Speciality Centre & Insulin Pump Centre is one of the most reputed and leading Diabetologists of Pune with an experience of more than 30 years. His special interests and expertise include prevention, diagnosis and managing various diabetes complications like Cardiovascular Diseases, Diabetic Foot Disease, Retinopathy (Eye Damage), Neuropathy (Nerve Damage), Skin Conditions etc. Dr. Erande is also a Panel Consultant at Joshi Hospital and Ratna Hospital and he is Hon. Physician to Pune Municipal Corporation. Dr. Erande is committed to help diabetes patients lead a healthy life and help them avoid diabetes complications in all their forms.

Disclosures

Assimilate requires every individual in a position to control educational content to disclose all financial relationships with ineligible companies that have occurred within the past 24 months. Ineligible companies are organizations whose primary business is producing, marketing, selling, re-selling, or distributing healthcare products used by or on patients. All relevant financial relationships for anyone with the ability to control the content of this educational activity have been reviewed and mitigated. Others involved in the planning of this activity have no relevant financial relationships.
Assimilate | Tackling NAFLD : Silent Epidemic